Circio Holding ASA

OB:CRNA Stock Report

Market Cap: NOK 26.3m

Circio Holding Management

Management criteria checks 4/4

Circio Holding's CEO is Erik Wiklund, appointed in Oct 2021, has a tenure of 2.67 years. total yearly compensation is NOK2.60M, comprised of 95.7% salary and 4.3% bonuses, including company stock and options. directly owns 0.031% of the company’s shares, worth NOK8.23K. The average tenure of the management team and the board of directors is 2.7 years and 3.9 years respectively.

Key information

Erik Wiklund

Chief executive officer

NOK 2.6m

Total compensation

CEO salary percentage95.7%
CEO tenure2.7yrs
CEO ownership0.03%
Management average tenure2.7yrs
Board average tenure3.9yrs

Recent management updates

Circio Holding ASA's (OB:CRNA) CEO Will Probably Struggle To See A Pay Rise This Year

May 29
Circio Holding ASA's (OB:CRNA) CEO Will Probably Struggle To See A Pay Rise This Year

Recent updates

Circio Holding ASA's (OB:CRNA) CEO Will Probably Struggle To See A Pay Rise This Year

May 29
Circio Holding ASA's (OB:CRNA) CEO Will Probably Struggle To See A Pay Rise This Year

Targovax ASA's (OB:TRVX) Intrinsic Value Is Potentially 96% Above Its Share Price

Aug 24
Targovax ASA's (OB:TRVX) Intrinsic Value Is Potentially 96% Above Its Share Price

Health Check: How Prudently Does Targovax (OB:TRVX) Use Debt?

Jul 08
Health Check: How Prudently Does Targovax (OB:TRVX) Use Debt?

Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Oct 27
Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Is Targovax (OB:TRVX) A Risky Investment?

Jul 05
Is Targovax (OB:TRVX) A Risky Investment?

Shareholders May Be A Bit More Conservative With Targovax ASA's (OB:TRVX) CEO Compensation For Now

Mar 10
Shareholders May Be A Bit More Conservative With Targovax ASA's (OB:TRVX) CEO Compensation For Now

Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Feb 20
Is Targovax (OB:TRVX) Using Debt In A Risky Way?

The Chief Scientific Officer of Targovax ASA (OB:TRVX), Victor Levitsky, Just Bought A Few More Shares

Dec 05
The Chief Scientific Officer of Targovax ASA (OB:TRVX), Victor Levitsky, Just Bought A Few More Shares

CEO Compensation Analysis

How has Erik Wiklund's remuneration changed compared to Circio Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023NOK 3mNOK 2m

-NOK 111m

Sep 30 2023n/an/a

-NOK 446m

Jun 30 2023n/an/a

-NOK 449m

Mar 31 2023n/an/a

-NOK 440m

Dec 31 2022NOK 4mNOK 3m

-NOK 433m

Sep 30 2022n/an/a

-NOK 107m

Jun 30 2022n/an/a

-NOK 110m

Mar 31 2022n/an/a

-NOK 106m

Dec 31 2021NOK 3mNOK 2m

-NOK 98m

Sep 30 2021n/an/a

-NOK 98m

Jun 30 2021n/an/a

-NOK 97m

Mar 31 2021n/an/a

-NOK 105m

Dec 31 2020NOK 3mNOK 2m

-NOK 108m

Sep 30 2020n/an/a

-NOK 117m

Jun 30 2020n/an/a

-NOK 120m

Mar 31 2020n/an/a

-NOK 132m

Dec 31 2019NOK 2mNOK 2m

-NOK 148m

Sep 30 2019n/an/a

-NOK 153m

Jun 30 2019n/an/a

-NOK 162m

Mar 31 2019n/an/a

-NOK 153m

Dec 31 2018NOK 2mNOK 2m

-NOK 147m

Sep 30 2018n/an/a

-NOK 139m

Jun 30 2018n/an/a

-NOK 132m

Mar 31 2018n/an/a

-NOK 129m

Dec 31 2017NOK 942kNOK 883k

-NOK 122m

Compensation vs Market: Erik's total compensation ($USD244.67K) is about average for companies of similar size in the Norwegian market ($USD315.98K).

Compensation vs Earnings: Erik's compensation has been consistent with company performance over the past year.

CEO

Erik Wiklund

2.7yrs

Tenure

NOK 2,603,000

Compensation

Dr. Erik Digman Wiklund serves as Chief Executive Officer of Circio Holding ASA (formerly known as Targovax ASA) since October 2021 and had been its Chief Business Officer since September 24, 2018 until Oc...

Leadership Team

NamePositionTenureCompensationOwnership
Erik Wiklund
Chief Executive Officer2.7yrsNOK 2.60m0.031%
NOK 8.2k
Lubor Gaal
Chief Financial Officer2.3yrsNOK 2.88mno data
Ola Melin
Chief Operating Officerless than a yearNOK 1.97m0.016%
NOK 4.1k
Thomas Hansen
Chief Technology Officerless than a yearNOK 1.97mno data
Victor Levitsky
Chief Scientific Officer4.1yrsNOK 790.00k0.0031%
NOK 823.7
Jon Eriksen
Special Advisor6.5yrsNOK 1.86mno data
Gustav Gaudernack
Chief Scientific Adviserno datano datano data
Peter Skorpil
Vice President of Business Development9.2yrsNOK 1.07mno data

2.7yrs

Average Tenure

Experienced Management: CRNA's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Diane Mellett
Independent Non-Executive Director8.8yrsNOK 371.00k0.038%
NOK 10.1k
Thomas Falck
Director2.2yrsNOK 357.00kno data
Robert Burns
Independent Director8.9yrsNOK 352.00k0.093%
NOK 24.6k
Damian Marron
Chairman of the Board4.2yrsNOK 589.00kno data
Dmitriy Zamarin
Member of Medical Advisory Board3.7yrsno datano data
Dean Fennell
Member of Scientific Advisory Board3.7yrsno datano data

3.9yrs

Average Tenure

63yo

Average Age

Experienced Board: CRNA's board of directors are considered experienced (3.9 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.